Publication date: December 2026 Source: International Journal of Gynecological Cancer, Volume 36, Issue 12 Author(s): Diletta Fumagalli, Aparna A. Kamat
Glucagon-like peptide-1 receptor agonist use in patients with gynecologic cancer: not if, but how, is the question. // International Journal of Gynecological Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1048891X26012156?dgcid=rss_sd_all
Glucagon-like peptide-1 receptor agonist use in patients with gynecologic cancer: not if, but how, is the question. International Journal of Gynecological Cancer. https://www.sciencedirect.com/science/article/pii/S1048891X26012156?dgcid=rss_sd_all
“Glucagon-like peptide-1 receptor agonist use in patients with gynecologic cancer: not if, but how, is the question.” International Journal of Gynecological Cancer.
@article{article49466,
title = {Glucagon-like peptide-1 receptor agonist use in patients with gynecologic cancer: not if, but how, is the question},
journal = {International Journal of Gynecological Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1048891X26012156?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment